Literature DB >> 24922093

Awareness and perception of human papilloma virus vaccine among healthcare professionals in Nigeria.

B M Audu1, M Bukar, A I Ibrahim, T Z Swende.   

Abstract

Human papilloma virus (HPV) is a necessary cause of cervical cancer and cervical cancer is largely a vaccine-preventable disease. The aim of the study was to document the knowledge of healthcare professionals of the HPV vaccine and its acceptability. It was a cross-sectional study in three of the six geo-political zones of Nigeria, carried out between June 2010 and January 2011. The 602 adult Nigerian respondents were made up of 147 (24.4%) males and 455 (75.6%) females aged 20-57 years, with a mean of 34.3 ± 7.9 years; most were under 40 years (70.1%) and married (n = 394; 65.5%). In total, 548 (91%) were aware of HPV; 83.4% knew HPV as an STI; 78.2% knew HPV can cause cervical cancer but only 265 (44.0%) were aware of the HPV vaccine. Among the healthcare professionals studied, nurses were the least aware of the existence of the HPV vaccine (χ(2) = 1.54, p = 0.001). A total of 489 (81.0%) would approve HPV vaccine for their teenage daughters. The men were more likely to accept the vaccination of their daughters than the women (χ(2) = 14.76, p = 0.002). The unmarried were more favourably disposed to vaccination of teenagers than the married (χ(2) = 27.37, p = 0.001). Safety concerns were the commonest reasons expressed by the 7% who were reluctant to accept the vaccination of their teenage daughters. In conclusion, healthcare providers are the custodians of health in a community, yet have low knowledge of a vaccine that can prevent the commonest cancer in women in sub-Saharan Africa.

Entities:  

Keywords:  Healthcare professional; human papilloma virus; perception

Mesh:

Substances:

Year:  2014        PMID: 24922093     DOI: 10.3109/01443615.2014.925431

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  11 in total

1.  Factors influencing the recommendation of the Human Papillomavirus vaccine by South African doctors working in a tertiary hospital.

Authors:  Muhammad Ehsanul Hoque
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

2.  Poor Knowledge of Human Papilloma Virus and Vaccination Among Respondents from Three Nigerian States.

Authors:  Angela O Eni; Mojisola G Soluade; Oghenevwairhe P Efekemo; Titilayo T Igwe; Olabode A Onile-Ere
Journal:  J Community Health       Date:  2018-12

3.  Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria.

Authors:  Mohammed Mohammed Manga; Adeola Fowotade; Yusuf Mohammed Abdullahi; Aliyu Usman El-Nafaty; Danladi Bojude Adamu; Hamidu Umar Pindiga; Rasheed Ajani Bakare; Abimbola Olu Osoba
Journal:  Infect Agent Cancer       Date:  2015-10-02       Impact factor: 2.965

4.  Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls.

Authors:  Azucena Bardají; Carolina Mindu; Orvalho J Augusto; Aina Casellas; Olga Cambaco; Egas Simbine; Graça Matsinhe; Eusébio Macete; Clara Menéndez; Esperança Sevene; Khátia Munguambe
Journal:  Papillomavirus Res       Date:  2018-04-14

5.  Healthcare professionals' level of medication knowledge in Africa: a systematic review.

Authors:  Derbew Fikadu Berhe; Katja Taxis; Flora M Haaijer-Ruskamp; Peter G M Mol
Journal:  Br J Clin Pharmacol       Date:  2018-10-14       Impact factor: 4.335

6.  Knowledge, Attitudes and Practices Towards Human Papillomavirus Vaccination Among Medical Doctors at a Tertiary Hospital: A Cross Sectional Study.

Authors:  Mwansa Ketty Lubeya; James Chisanga Zekire Nyirenda; Jane Chanda Kabwe; Moses Mukosha
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

Review 7.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809

8.  Acceptability of multipurpose human papillomavirus vaccines among providers and mothers of adolescent girls: A mixed-methods study in five countries.

Authors:  Nadja A Vielot; Shoshana K Goldberg; Gregory Zimet; Sara B Smith; Mary Anne McDonald; Silvina Ramos; Karen Morgan; Chan Joo Kim; Karin L Richter; Merce Peris; Kevin J Whaley; Jennifer S Smith
Journal:  Papillomavirus Res       Date:  2017-04-06

9.  Health systems constraints and facilitators of human papillomavirus immunization programmes in sub-Saharan Africa: a systematic review.

Authors:  Edina Amponsah-Dacosta; Benjamin M Kagina; Jill Olivier
Journal:  Health Policy Plan       Date:  2020-07-01       Impact factor: 3.344

10.  Prevalence and Type Distribution of Human Papillomaviruszzm321990Recovered from the Uterine Cervix of Nigerian Women:zzm321990A Systematic Review and Meta-Analysis

Authors:  Auwal Idris Kabuga; Ahmad Nejati; Amanuel Godana Arero; Somayeh Jalilvand; Talat Mokhtari-Azad; Shirin Shahbazi Sighaldeh; Umma Hassan Wali; Shohreh Shahmahmoodi; Mohamed E El Zowalaty
Journal:  Asian Pac J Cancer Prev       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.